Nasdaq Stock Market LLC filed a notification of removal from listing and registration on November 13, 2026, covering HeartBeam, Inc.'s warrants under Section 12(b) of the Securities Exchange Act of 1934.

Key Highlights

  • Issuer: HeartBeam, Inc., a cardiac health technology company listed on Nasdaq under commission file number 001-41060.
  • Security removed: The class of securities described as "Warrant" is being struck from listing and registration on the Nasdaq Stock Market.
  • Exchange action: Nasdaq Stock Market LLC certified it complied with its own rules to strike the warrants from listing, pursuant to 17 CFR 240.12d2-2(b).
  • Signing authority: The notification was signed by Tara Petta, AVP at Nasdaq Stock Market LLC, dated November 13, 2026.
  • Regulatory basis: The filing invokes 17 CFR 240.12d2-2(b), indicating the removal was initiated by the exchange rather than voluntarily by the issuer.

Nasdaq Initiates Warrant Delisting for HeartBeam Under Exchange Rules

According to the filing, Nasdaq Stock Market LLC submitted a Form 25 notification on November 13, 2026, to remove HeartBeam, Inc.'s warrants from listing and registration under Section 12(b) of the Securities Exchange Act of 1934. HeartBeam, Inc., headquartered in Santa Clara, California, holds commission file number 001-41060 and is a medical technology company focused on cardiac health monitoring solutions. The filing identifies the affected class of securities simply as "Warrant."

The filing discloses that the exchange relied upon 17 CFR 240.12d2-2(b) as the regulatory basis for the removal, indicating that Nasdaq, rather than the issuer, initiated the delisting action. Under that provision, the exchange certifies it has complied with its own rules in striking the class of securities from listing and withdrawing registration. The notification was signed by Tara Petta, identified as AVP, on behalf of Nasdaq Stock Market LLC. The filing further notes that the Form 25 and an attached notice are considered compliance with 17 CFR 240.19d-1 as applicable.

The filing does not indicate any voluntary withdrawal by HeartBeam under 17 CFR 240.12d2-2(c), which would apply if the issuer itself had sought to withdraw the securities. No financial metrics, share counts, or prices are disclosed within this notification. The company's common stock listing status on NASDAQ:BEAT is not addressed within the scope of this filing, which pertains exclusively to the warrant class.

What Was Disclosed

Nasdaq Stock Market LLC notified the SEC on November 13, 2026, that it was removing HeartBeam, Inc.'s warrants from listing and registration under exchange-initiated rules, with Tara Petta signing on behalf of Nasdaq as AVP.